Logo Medical Data Models (MDM) Portal Logo Westfälische Wilhelms-Universität (WWU)
Information:
Error:
en ▾
  • Deutsch
  • English
  • Español
  • Italiano
  • Français
  • Português
  • Svenska
  • Nederlands
  • Login
  • Register
  • Search
  • ODM-XML file upload
  • Create data model
  • ODM-Edit tool
  • Metadata Registry
  • Help
  • About the MDM portal
  • Imprint
  • Login
  • Register
Actions ▾
  • ODM-XML file upload
  • Create data model
  • ODM-Edit tool
  • Metadata Registry
  • About the MDM portal
en ▾
  • Deutsch
  • English
  • Español
  • Italiano
  • Français
  • Português
  • Svenska
  • Nederlands

Search through specific fields of a model

The name of the data model contains study:
name:"study"
The description contains two terms:
description:"double blind"
The copyrightholder contains the term UKM:
copyrightholder:"UKM"
The uploader of the model is Martin Dugas:
uploader:"Martin Dugas"
The keywords contain cancer:
keyword:"cancer"

Refine the search with search operators

Search for groups of words with quotes:
"leukemia myeloid"
Use a wildcard to search for prefixes:
NCT*
With AND/OR/NOT find study without eye nor ear:
study AND NOT (eye OR ear)
Cancer must (+) occur, study not (-):
+cancer -study
You may connect the different search techniques:
name:"form*" AND routine
  • Filter search results
Keywords
Eligibility Determination ×
Carcinoma, Hepatocellular ×
  • Clinical Trial  (144)
  • Gastroenterology  (125)
  • Liver Cirrhosis  (3)
  • Carcinoma  (2)
  • Hepatitis B  (2)
  • Vitamin D  (1)
  • Liver Transplantation  (1)
  • Clinical Trial, Phase III  (1)
  • Probiotics  (1)
  • Drug trial  (1)
  • Contrast Media  (1)
  • Embolization, Therapeutic  (1)
  • Fibrosis  (1)
  • Liver Diseases  (1)
  • Magnetic Resonance Imaging  (1)
  • Medical Oncology  (1)
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
  • Select data models
Selected data models

You must log in to select data models for download or further analysis.

160 Search results.

Sort (Relevance) ▾
  • Relevance
  • Rating
  • New first
  • Old first

Eligibility Hepatocellular Carcinoma NCT01759901

- 10/7/20 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01759901
  • Eligibility Determination
  • Carcinoma, Hepatocellular
  • Clinical Trial

Eligibility Probiotics before Liver Resection in Liver Disease NCT02021253

- 10/7/20 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Influence of Probiotics Administration Before Liver Resection in Liver Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02021253
  • Probiotics
  • Eligibility Determination
  • Clinical Trial
  • Liver Cirrhosis
  • Carcinoma, Hepatocellular
  • Fibrosis
  • Liver Diseases

Eligibility Localized Non-Resectable Adult Hepatocellular Carcinoma NCT01910909

- 7/2/20 - 1 form, 2 itemgroups, 24 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Stereotactic Body Radiotherapy for Unresectable Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01910909
  • Carcinoma, Hepatocellular
  • Clinical Trial
  • Eligibility Determination
  • Gastroenterology

Eligibility Liver Carcinoma NCT01482442

- 6/29/20 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01482442
  • Eligibility Determination
  • Clinical Trial
  • Gastroenterology
  • Carcinoma, Hepatocellular

Eligibility Hepatocellular Carcinoma NCT01281683

- 6/12/20 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT01281683
  • Carcinoma, Hepatocellular
  • Clinical Trial
  • Eligibility Determination
  • Gastroenterology

Eligibility Hepatocellular Carcinoma NCT02182687

- 6/6/20 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant; ODM derived from: https://clinicaltrials.gov/show/NCT02182687
  • Carcinoma, Hepatocellular
  • Clinical Trial
  • Eligibility Determination
  • Gastroenterology

Eligibility Hepatocellular Carcinoma NCT01968629

- 6/6/20 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
24hr Imaging Of HCC After EOVIST; ODM derived from: https://clinicaltrials.gov/show/NCT01968629
  • Clinical Trial
  • Gastroenterology
  • Carcinoma, Hepatocellular
  • Eligibility Determination

Eligibility Hepatocellular Carcinoma NCT02267213

- 6/6/20 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety Study of TLC388 to Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02267213
  • Eligibility Determination
  • Gastroenterology
  • Carcinoma, Hepatocellular
  • Clinical Trial

Eligibility Hepatocellular Carcinoma NCT00862082

- 6/5/20 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC); ODM derived from: https://clinicaltrials.gov/show/NCT00862082
  • Eligibility Determination
  • Carcinoma, Hepatocellular
  • Clinical Trial
  • Gastroenterology

Eligibility Hepatocellular Carcinoma NCT00669136

- 6/5/20 - 1 form, 2 itemgroups, 21 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00669136
  • Carcinoma, Hepatocellular
  • Gastroenterology
  • Clinical Trial
  • Eligibility Determination

Eligibility Hepatocellular Carcinoma NCT01686880

- 6/5/20 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver; ODM derived from: https://clinicaltrials.gov/show/NCT01686880
  • Clinical Trial
  • Eligibility Determination
  • Carcinoma, Hepatocellular
  • Gastroenterology

Eligibility Hepatocellular Carcinoma NCT00906373

- 6/5/20 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of IMC-A12 in Combination With Sorafenib in Patients With Advanced Cancer of the Liver; ODM derived from: https://clinicaltrials.gov/show/NCT00906373
  • Gastroenterology
  • Eligibility Determination
  • Clinical Trial
  • Carcinoma, Hepatocellular
  • 1
  • 2 (current)
  • 3
  • 4
  • 5
  • …
  • 14
  • >

Contact

Institute of Medical Informatics
Director: Prof. Dr. Martin Dugas
Albert-Schweitzer-Campus 1, A11
48149 Münster, Germany
Email : imi@uni-muenster.de

In collaboration with

Logo DFG Logo ERCIS Logo IMI Logo CatRIS Logo ULB Logo IH-D Logo Toolpool Logo EFMI
  • Imprint
  • Disclaimer
  • Data Privacy
© 2021  University of Münster
  • Contact
  • Help
  • Cite

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Login

Forgot password?


Register